Related Experiment Video
Updated: Jul 22, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism
Jonuelle Acosta1,2, Qinglan Li1, Nelson F Freeburg1,2
1Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Abstract:
The p53 tumor suppressor regulates multiple context-dependent tumor suppressive programs. Although p53 is mutated in ~90% of small cell lung cancer (SCLC) tumors, how p53 mediates tumor suppression in this context is unknown. Here, using a mouse model of SCLC in which endogenous p53 expression can be conditionally and temporally regulated, we show that SCLC tumors maintain a requirement for p53 inactivation. However, we identify tumor subtype heterogeneity between SCLC tumors such that p53 reactivation induces senescence in a subset of tumors, while in others, p53 induces necrosis. We pinpoint cyclophilins as critical determinants of a p53-induced transcriptional program that is specific to SCLC tumors and cell lines poised to undergo p53-mediated necrosis. Importantly, inhibition of cyclophilin isomerase activity, or genetic ablation of specific cyclophilin genes, suppresses p53-mediated necrosis by limiting p53 transcriptional output without impacting p53 chromatin binding. Our study demonstrates that intertumoral heterogeneity in SCLC influences the biological response to p53 restoration, describes a cyclophilin-dependent mechanism of p53-regulated cell death, and uncovers putative mechanisms for the treatment of this most-recalcitrant tumor type.
Insights
Restoring tumor suppressor p53 in small cell lung cancer (SCLC) triggers cell death, but the mechanism depends on tumor subtype. Cyclophilins control p53-induced necrosis, offering potential therapeutic targets for SCLC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 tumor suppressor is crucial for preventing cancer but its role in small cell lung cancer (SCLC) is unclear.
- p53 is frequently mutated in SCLC, yet its precise function in tumor suppression within this context remains largely unknown.
Purpose of the Study:
- To investigate how p53 mediates tumor suppression in SCLC.
- To explore the heterogeneity of p53's effects and identify molecular mechanisms driving cell death in SCLC.
Main Methods:
- Utilized a conditional mouse model of SCLC with regulated p53 expression.
- Analyzed tumor subtype heterogeneity and identified cyclophilins as key regulators.
- Investigated the impact of cyclophilin inhibition on p53-mediated cell death.
Main Results:
- SCLC tumors require p53 inactivation but exhibit heterogeneity in response to p53 reactivation.
- p53 reactivation induces either senescence or necrosis depending on the tumor subtype.
- Cyclophilins are essential for a p53-induced transcriptional program leading to necrosis in specific SCLC subtypes.
- Inhibiting cyclophilin activity suppresses p53-mediated necrosis by modulating p53 transcriptional output.
Conclusions:
- Intertumoral heterogeneity in SCLC dictates the cellular response to p53 restoration.
- A cyclophilin-dependent mechanism regulates p53-induced necrosis in SCLC.
- Targeting cyclophilins presents a potential therapeutic strategy for treating SCLC.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Inhibition of Cdk Activity
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...